Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer–Norfolk Cohort | Zendy

Effrossyni GkraniaKlotsas | Zendy; Claudia Langenberg | Zendy; Stephen J. Sharp | Zendy; Robert Luben | Zendy; KayTee Khaw | Zendy; Nicholas J. Wareham | Zendy

Open Access

Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer–Norfolk Cohort

Author(s) -

Effrossyni GkraniaKlotsas,

Claudia Langenberg,

Stephen J. Sharp,

Robert Luben,

KayTee Khaw,

Nicholas J. Wareham

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit083

Subject(s) - medicine , hazard ratio , prospective cohort study , confidence interval , population , cohort , immunology , cohort study , mortality rate , demography , environmental health , sociology

The relationship between cytomegalovirus (CMV) infection and mortality among immunocompetent individuals is uncertain. We aimed to examine whether seropositivity for CMV and the level of CMV immunoglobulin G (IgG) antibody are associated with all-cause and cause-specific mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research